Discontinuation of antipsychotic medication-time to rethink trial design

Speyer, H., Begemann, M., Albert, N., Weller, A., Nordentoft, M., Veling, W., Sommer, I. E., Allott, K. & Killackey, E., Oct-2020, In : The Lancet. Psychiatry. 7, 10, p. 841-842 2 p.

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Copy link to clipboard


  • Discontinuation of antipsychotic medication—time to rethink trial design

    Final publisher's version, 1.43 MB, PDF document

    Request copy


Original languageEnglish
Pages (from-to)841-842
Number of pages2
JournalThe Lancet. Psychiatry
Issue number10
Publication statusPublished - Oct-2020


  • Antipsychotic Agents/therapeutic use, Humans, Medication Adherence, Patient Dropouts, Patient Selection, Psychotic Disorders/drug therapy, Randomized Controlled Trials as Topic, Recurrence, Research Design

ID: 136300772